CHEMOMAB THERAPEUTICS LTD. - AMERICAN DEPOSITARY

1.9315

11-February-25 15:45:00

15 minutes delayed

Stocks

-0.0585

-2.94%

Today's range

1.9000 - 2.0050

ISIN

N/A

Source

NASDAQ

Chemomab Therapeutics to Report First Quarter 2024 Financial Results and Provide a Business Update

24 Apr 2024 06:00:00 By Nasdaq GlobeNewswire
Chemomab Reports New Peer-Reviewed Publication Reinforcing the Clinical Association of Its CCL24 Target with Disease Severity and Mortality in Patients with Systemic Sclerosis

18 Apr 2024 06:00:00 By Nasdaq GlobeNewswire
Chemomab to Host Virtual Key Opinion Leader Webinar on Primary Sclerosing Cholangitis on April 10, 2024

02 Apr 2024 06:00:00 By Nasdaq GlobeNewswire
Chemomab Awarded New European Patent for CM-101, Its First-in Class Monoclonal Antibody in Phase 2 Clinical Development for Primary Sclerosing Cholangitis

25 Mar 2024 06:06:46 By Nasdaq GlobeNewswire

<<
<
1
2
>

I Agree NetDania's website uses cookies. By continuing browsing our website, you agree to our Cookie Policy, Privacy Policy and Terms and Conditons.